FINEME / COMPANY INTELLIGENCE

Company Intelligence

See what changed in published company financial reports, follow the businesses you care about, and compare a small sample from the same industry. Figures are historical—not share prices or investment recommendations.

My World ↗Compare companies ↗

01 / MY COMPANY WATCHLIST

Your followed companies

Read the latest financial periods and filing-list dates saved for companies you follow in My World.

Manage in My World →

Loading followed companies…

Followed companies and last-check comparisons are kept in this browser only. A changed badge means stored information changed since this browser last checked, not that a new filing occurred at that moment.

02 / FIND A BUSINESS

Browse the company directory

Search by name, ticker or CIK. Browse all matching listings, including companies without available analysis.

ACTEnact Holdings, Inc.

Inspect →

ACTGACACIA RESEARCH CORP

Inspect →

ACTUACTUATE THERAPEUTICS, INC.

Inspect →

ACUACME UNITED CORP

Inspect →

ACUTAccustem Sciences Inc.

Inspect →

ACVVirtus Diversified Income & Convertible Fund

Inspect →

ACVAACV Auctions Inc.

Inspect →

ACXPAcurx Pharmaceuticals, Inc.

Inspect →

ADARRAY DIGITAL INFRASTRUCTURE, INC.

Inspect →

ADACAmerican Drive Acquisition Co

Inspect →

ADAGAdagene Inc.

Inspect →

ADAMADAMAS TRUST, INC.

Inspect →

03 / FINANCIAL CHANGES

Kura Oncology, Inc. KURA

Pharmaceutical Preparations · SIC 2834

Full analysis →

Latest standalone quarter

Period ending 2026-09-30

Filed: 2026-11-10 · Retrieved: 2026-11-11

Compared with the same period of the prior year, ending 2025-09-30.

Revenue22.84

USD million

Change year over year: +2.09 · +10.1%

Net income-70.22

USD million

Change year over year: +3.90

Operating cash flow-54.44

USD million

Change year over year: +26.18

Total liabilities548.54

USD million

Change year over year: +141.70

Total assets566.50

USD million

Change year over year: -82.88

Liabilities / assets: 96.8% · Change: +34.2 percentage points

Open original filing ↗

Latest annual report

Period ending 2025-12-31

Filed: 2026-03-05 · Retrieved: 2026-11-11

Compared with the same period of the prior year, ending 2024-12-31.

Revenue67.48

USD million

Change year over year: +13.60 · +25.2%

Net income-278.67

USD million

Change year over year: -104.68

Operating cash flow-64.06

USD million

Change year over year: -198.38

Total liabilities564.23

USD million

Change year over year: +217.71

Total assets738.36

USD million

Change year over year: -21.80

Liabilities / assets: 76.4% · Change: +30.8 percentage points

Open original filing ↗

04 / INDUSTRY CONTEXT

Other companies with the same SIC classification

A small, non-ranked sample of available annual reports. Periods and business models may differ.

Company	Period ending	Revenue (USD million)	Net margin	Operating cash margin
ABUS ↗	2025-12-31	14.08	-237.9%	-281.5%
TNXP ↗	2025-12-31	13.11	-946.2%	-761.8%
WHWK ↗	2025-12-31	7.15	-288.3%	-1,363.7%
IBIO ↗	2026-06-30	0.10	-33,044.0%	-23,218.0%
PBYI ↗	2025-12-31	228.37	13.6%	18.3%
OCUL ↗	2025-12-31	51.95	-511.9%	-394.4%

Same SIC does not prove businesses are direct competitors. Annual periods may differ; margins may not be meaningful for every industry. Missing data are not zero and this is not a stock ranking.

05 / RECENT FINANCIAL RECORDS

Recently filed reports in the imported dataset

These are the newest filing dates found in the locally available annual and quarterly financial records. Not a real-time SEC feed; late imports and amended filings may affect what appears.

Latest standalone quarter

ABUS ↗

Arbutus Biopharma Corp

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

MRDN ↗

Meridian Holdings Inc./NV

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

KURA ↗

Kura Oncology, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

IBIO ↗

iBio, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

SNWV ↗

SANUWAVE Health, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

BNGO ↗

Bionano Genomics, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

GEVO ↗

Gevo, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

AVNW ↗

AVIAT NETWORKS, INC.

Filed: 2026-11-10
Period ending: 2026-10-02

Latest standalone quarter

NCMI ↗

National CineMedia, Inc.

Filed: 2026-11-10
Period ending: 2026-10-01

Latest annual report

SBH ↗

Sally Beauty Holdings, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

SNOA ↗

Sonoma Pharmaceuticals, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

PALI ↗

PALISADE BIO, INC.

Filed: 2026-11-10
Period ending: 2026-09-30

Interpret the evidence carefully

Company figures are historical, sometimes revised and not necessarily from the same period. This tool does not include live stock prices, valuation, a prediction of future performance, or guaranteed real-time filing alerts. Use source filings to verify decisions.

Data sources and methodology →